HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 519009Generated: October 30, 2026
Tetra-n-butylammonium tribromide → HCID 86727364, compound
https://huagongshe.com/reaction/519009
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetra-n-butylammonium tribromide | HCID 23500184 | — |
| Reactant | HCID 86727365 | HCID 86727365 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 86727364 | HCID 86727364 | 57% |
Reaction Steps
To a solution of 4-(4-methyl-3-oxo-2,3,4,10-tetrahydro-9-oxa-1,2,4a-triaza-phenanthren-6-yl)-piperidine-1-carboxylic acid tert-butyl ester (Example #71, Step B, 0.50 g, 1.249 mmol) in DCM (5 mL) and MeOH (5 mL) was added tetrabutylammonium tribromide (0.662 g, 1.373 mmol) in portions and the mixture was stirred for 30 min at ambient temperature. The reaction was quenched by addition of saturated aqueous Na2S2O3 solution (5 mL) and the pH was adjusted to 7 with saturated aqueous NaHCO3 solution. The mixture was extracted with DCM (3×20 mL). The combined organic phase was washed with brine (20 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was purified by column chromatography on silica gel (eluting with 20% EtOAc in petroleum ether) to give 4-(7-bromo-4-methyl-3-oxo-2,3,4,10-tetrahydro-9-oxa-1,2,4a-triaza-phenanthren-6-yl)-piperidine-1-carboxylic acid tert-butyl ester (0.34 g, 57%). LC/MS (Table 1, Method 2) Rt=1.289 min.; MS m/z: 479/481 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09115151B2 |
|---|
| Source dataset | uspto-grants-2015_08 |
|---|
| ORD ID | ord-077136fe96f243bb8426a71ff3a1dec1 |
|---|
| Source note | uspto-grants-2015_08 |
|---|